More News

• • Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
    July 28, 2025 | Press Release
  • Agreement Between Embolx and Varian Paves the Way for Advanced Image-Guided Therapies for Cancer
    March 28, 2025 | Press Release
  • New Soldier High-Flow Microcatheter Granted FDA Clearance
  • February 29, 2024 | Press Release
  • Embolx Inc and Girlow USA Join Forces to Expand Distribution into South America
  • November 1, 2023 | Press Release
  • Embolx Signs International Distribution Agreement
  • March 16, 2023 |Press Release
  • Embolx Files 510(K) for New Soldier High Flow Microcatheter
  • July 21, 2022 | Press Release

  • Embolx Launches Sniper into the European Market

    June 8, 2021 | Press Release

  • Embolx Extends the Sniper Balloon Occlusion Microcatheter Family with Launch of New K-Tip Design (US)

May 9, 2019 | Press Release

• • Minimally Invasive Treatments Grab BPH Spotlight

January 30, 2019 | Urology Times

• • Embolx Earns CE Mark Certification of Sniper Balloon Occlusion Microcatheter to Deliver Pressure-Directed Therapy for Tumors, Enlarged Prostate, Fibroids

    August 31, 2018 | Press Release

  • Start-Up Spotlight: Embolx Believes Balloon Microcatheter Occlusion Will Be A ‘Breakthrough’ For BPH, Cancer

    August 1, 2018 | Medtech Insight

  • Embolx Announces FDA Clearance of Next Generation Sniper Balloon Occlusion Microcatheter to Deliver Pressure-Directed Therapy for Tumors, Enlarged Prostate and Fibroids

    June 28, 2018 | Press Release

  • Embolx Signs Agreement With U.S. Department of Veterans Affairs for Sniper Balloon Occlusion Microcatheter

    May 22, 2018 | Press Release

  • National Institutes of Health Awards Embolx Phase II SBIR Grant for Further Development of Pressure-Directed Embolization Therapy

    April 6, 2018 | Press Release